Immunohistochemistry and in situ hybridization analyses demonstrated tumor cells positive for cluster of differentiation 20 (CD20), CD19, paired box 5 (PAX5), CD10, B cell lymphoma 6 (Bcl6), and Bcl2 (approximately 80%). This evidence concerns the gene PAX5 and neoplasm.